On Tuesday, Following U.S. Stocks were among the “Top Gainers“: Nanosphere, Inc (NASDAQ:NSPH), AMAG Pharmaceuticals, Inc (NASDAQ:AMAG), HealthSouth Corp (NYSE:HLS), Comstock Resources Inc (NYSE:CRK)
Nanosphere, Inc (NASDAQ:NSPH)’s shares picked up 1.92%, and closed at $0.265. The company has the market capitalization of $ 30.50M. In the last trading session 1.06M shares changed hands as compared to its average volume of 3.98M shares. The beta value of the stock is 3.55. On the other hand the stock’s volatility for the week is 11.66%, and for the month is 17.61%. The stock price to book value is $1.06, however price to sale value is $2.17. Analyst’s mean recommendation regarding this stock is 2.40. (where 1=Buy, 5=Sale).
Nanosphere, Inc. develops, manufactures, and markets molecular diagnostic tests that can lead to earlier disease detection, optimal patient treatment, and improved healthcare economics. It offers a molecular diagnostics platform, Verigene System platform that enables clinicians to identify and treat the bacteria and viruses for complex, costly, and deadly infectious diseases.
AMAG Pharmaceuticals, Inc (NASDAQ:AMAG), raised 1.91%, and closed at $52.78, hitting new 52-week high of $53.28. The stock has the beta value of 0.18, and its volatility for the week is 4.43%, while for the month it is 4.49%. The company has the market capitalization of $ 1.53B. The company holds the book value per share of 19.22, whereas cash per share is 4.87. Price to book value is estimated to be 2.75, while price to sale value is 12.55. Analysts mean recommendation for the stock is said to be 1.50 (where 1=Buy, 5=sale).
AMAG Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that focuses on maternal health, anemia, and cancer supportive care. It markets Makena, a hydroxyprogesterone caproate injection to reduce the risk of preterm birth in women with a singleton pregnancy; Feraheme (ferumoxytol) injection for use as an intravenous (IV) iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease; and MuGard Mucoadhesive Oral Wound Rinse for the administration of oral mucocitis/stomatiits and various types of oral wounds.
HealthSouth Corp (NYSE:HLS), enhanced 1.80%, and closed at $41.78. The company holds the market capitalization of 3.59M. For the trailing twelve months, the stock’s return on equity value remains 61.00%, while return on assets value is 9.10%, in response to its return on investment value of 13.20%. Its 20-day moving average declined -4.99%, below 50-day moving average of -1.23%, above 200-day moving average of 6.83% from the latest market price of $41.78. The mean recommendation of analysts for this stock is 2.20.(where 1=Buy, 5=Sale).
HealthSouth Corporation owns and operates inpatient rehabilitation hospitals in the United States. The company provides specialized rehabilitative treatment on an inpatient and outpatient basis. Its inpatient rehabilitation hospitals offer specialized rehabilitative care services to patients in various disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Comstock Resources Inc (NYSE:CRK), rose 1.76%, and closed at $4.63. The stock has price to sale value of 0.40, however, price to book value is 0.25. With recent incline, the year-to-date (YTD) performance reflected a -31.41% decline above last year. During the past month the stocks lose -8.32%, bringing three-month performance to -20.31% and six-month performance to -78.18%. The mean recommendation of analysts for this stock is 2.70. (where 1=Buy, 5=Sale).
Comstock Resources, Inc., an independent energy company, attains, develops, explores, and produces oil and natural gas properties in the United States. Its oil and gas operations are primarily located in East Texas/North Louisiana and South Texas.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
